Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Viral Vaccines market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Viral Vaccinesmarket, defines the market attractiveness level of Viral Vaccines market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Viral Vaccines industry, describes the types of Viral Vaccines market, the applications of major players and the market size, and deeply analyzes the current situation of the global Viral Vaccines market and the development prospects and opportunities of Viral Vaccines industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Viral Vaccines market in Chapter 13.
By Player:
Bayer
Zoetis
Johnson
Pfizer
GSK
Novartis
Merck
AstraZeneca
CSL
Sanofi
By Type:
Attenuated Vaccine
Inactivated Vaccine
By End-User:
Hospital
Pharmaceutical Factory
Research Institute
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Viral Vaccines Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Viral Vaccines Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Viral Vaccines Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Viral Vaccines Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Viral Vaccines Market Analysis and Outlook to 2022
-
7.1 Global Viral Vaccines Consumption (2017-2022)
-
7.2 United States Viral Vaccines Consumption (2017-2022)
-
7.3 Europe Viral Vaccines Consumption (2017-2022)
-
7.4 China Viral Vaccines Consumption (2017-2022)
-
7.5 Japan Viral Vaccines Consumption (2017-2022)
-
7.6 India Viral Vaccines Consumption (2017-2022)
-
7.7 South Korea Viral Vaccines Consumption (2017-2022)
8 Region and Country-wise Viral Vaccines Market Analysis and Outlook to 2028
-
8.1 Global Viral Vaccines Consumption Forecast (2022-2028)
-
8.2 United States Viral Vaccines Consumption Forecast (2022-2028)
-
8.3 Europe Viral Vaccines Consumption Forecast (2022-2028)
-
8.4 China Viral Vaccines Consumption Forecast (2022-2028)
-
8.5 Japan Viral Vaccines Consumption Forecast (2022-2028)
-
8.6 India Viral Vaccines Consumption Forecast (2022-2028)
-
8.7 South Korea Viral Vaccines Consumption Forecast (2022-2028)
9 Global Viral Vaccines Market Outlook by Types and Applications to 2022
-
9.1 Global Viral Vaccines Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Attenuated Vaccine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Inactivated Vaccine Consumption and Growth Rate (2017-2022)
-
9.2 Global Viral Vaccines Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Pharmaceutical Factory Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Institute Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Viral Vaccines Market Outlook by Types and Applications to 2028
-
10.1 Global Viral Vaccines Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Viral Vaccines Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Pharmaceutical Factory Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Viral Vaccines Import and Export Analysis (Top 5 Countries)
-
11.1 Global Viral Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Viral Vaccines Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Viral Vaccines Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Viral Vaccines Market Competitive Analysis
-
14.1 Bayer
-
14.1.1 Bayer Company Details
-
14.1.2 Bayer Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Bayer Viral Vaccines Product and Service
-
14.2 Zoetis
-
14.2.1 Zoetis Company Details
-
14.2.2 Zoetis Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Zoetis Viral Vaccines Product and Service
-
14.3 Johnson
-
14.3.1 Johnson Company Details
-
14.3.2 Johnson Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Johnson Viral Vaccines Product and Service
-
14.4 Pfizer
-
14.4.1 Pfizer Company Details
-
14.4.2 Pfizer Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Viral Vaccines Product and Service
-
14.5 GSK
-
14.5.1 GSK Company Details
-
14.5.2 GSK Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 GSK Viral Vaccines Product and Service
-
14.6 Novartis
-
14.6.1 Novartis Company Details
-
14.6.2 Novartis Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Novartis Viral Vaccines Product and Service
-
14.7 Merck
-
14.7.1 Merck Company Details
-
14.7.2 Merck Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Merck Viral Vaccines Product and Service
-
14.8 AstraZeneca
-
14.8.1 AstraZeneca Company Details
-
14.8.2 AstraZeneca Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 AstraZeneca Viral Vaccines Product and Service
-
14.9 CSL
-
14.9.1 CSL Company Details
-
14.9.2 CSL Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 CSL Viral Vaccines Product and Service
-
14.10 Sanofi
-
14.10.1 Sanofi Company Details
-
14.10.2 Sanofi Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Sanofi Viral Vaccines Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Viral Vaccines
-
Figure Viral Vaccines Picture
-
Table Global Viral Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Viral Vaccines Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Viral Vaccines Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Viral Vaccines Consumption by Country (2017-2022)
-
Figure United States Viral Vaccines Consumption and Growth Rate (2017-2022)
-
Table Europe Viral Vaccines Consumption and Growth Rate (2017-2022)
-
Figure China Viral Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Japan Viral Vaccines Consumption and Growth Rate (2017-2022)
-
Figure India Viral Vaccines Consumption and Growth Rate (2017-2022)
-
Figure South Korea Viral Vaccines Consumption and Growth Rate (2017-2022)
-
Figure Global Viral Vaccines Consumption Forecast by Country (2022-2028)
-
Figure United States Viral Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Viral Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Viral Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Viral Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Viral Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Viral Vaccines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Attenuated Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Inactivated Vaccine Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmaceutical Factory Consumption and Growth Rate (2017-2022)
-
Figure Global Research Institute Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Attenuated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inactivated Vaccine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmaceutical Factory Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Institute Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Viral Vaccines Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Viral Vaccines Export by Region (Top 5 Countries) (2017-2028)
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Viral Vaccines Product and Service
-
Table Zoetis (Foundation Year, Company Profile and etc.)
-
Table Zoetis Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zoetis Viral Vaccines Product and Service
-
Table Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson Viral Vaccines Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Viral Vaccines Product and Service
-
Table GSK (Foundation Year, Company Profile and etc.)
-
Table GSK Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table GSK Viral Vaccines Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Viral Vaccines Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Viral Vaccines Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Viral Vaccines Product and Service
-
Table CSL (Foundation Year, Company Profile and etc.)
-
Table CSL Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table CSL Viral Vaccines Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Viral Vaccines Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Viral Vaccines Product and Service
-
